Compared with the cardiac hypertrophy group, the expressions of Cys-C, Wnt2, β-catenin and WISP-1 significantly decreased in the low- and high-dose tanshinone IIA groups (both P < 0.05). Here, CCN4 is linked to cardiac hypertrophy.